je.st
news
Tag: hepatitis
UPDATE 1-Britain's cost agency not ready to back Gilead hepatitis C drug
2014-06-16 22:27:05| Biotech - Topix.net
Britain's healthcare cost-effectiveness watchdog said on Monday it needed more information about Gilead Sciences' pricey new hepatitis C drug Sovaldi before deciding if it should be used on the state health service.
New hepatitis C wonder drug shakes up the health care industry
2014-06-13 01:45:38| Biotech - Topix.net
In December 2013, Sovaldi won approval from the U.S. Food and Drug Administration, and Roth, of San Rafael, Calif., was placed on a 24-week treatment regimen.
Tags: health
care
industry
drug
Merck challenges Gilead with $3.85B hepatitis C acquisition
2014-06-10 05:02:20| Biotech - Topix.net
Merck will spend about $3.85 billion for Idenix Pharmaceuticals, a small company developing hepatitis C medicines that, together with Merck's experimental drugs, could produce lucrative combo therapies that quickly cure most patients with the blood-borne virus afflicting tens of millions.
Tags: challenges
acquisition
hepatitis
merck
Demand for expensive hepatitis C drug strains insurers
2014-06-01 05:22:56| Biotech - Topix.net
Laurel Welch, a retired nurse from Barnstable, was exposed to hepatitis C 25 years ago.
Tags: drug
demand
expensive
strains
UPDATE 1-U.S. health insurers say Gilead hepatitis C drug too costly
2014-05-21 03:50:55| Biotech - Topix.net
The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines, accusing drugmakers of taking advantage of the insurance system by pricing products at unsustainable levels.
Sites : [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] next »